Professor Frank Ng of Monash University in Australia created AOD-9604 (Advanced Obesity Medicine) to identify a fat-burning anti-obesity drug without the muscle-building properties of human growth hormone (HGH).
A tiny area at one end of the HGH molecule seems to influence the fat-reducing effects of the hormone, according to Monash University researchers. Only around 10% of the whole molecule is made up of this area, which seems to have little influence on growth or insulin resistance. Instead of negatively impacting blood sugar levels or growth as found with unmodified HGH, it mimics the way natural HGH controls fat metabolism.
Many studies have shown the lipolytic (fat burning) and anti-lipogenic effects of AOD-96004. Lipolysis (the disintegration or destruction of fat) and lipogenesis (the conversion of fatty dietary items into body fat) are both stimulated and inhibited by AOD-9604, much as Growth Hormone is. Recent clinical trials have revealed that AOD-9604 reduces mid-abdominal body fat in both obese and overweight adults, as well as in those of average build.
AOD-9604 liberated fat from obese fat cells, but not from lean ones, in laboratory testing on rats, pigs, dogs, and humans. It also decreased new fat formation in all fat cells and increased fat burning. Rats and mice were treated with AOD-9604, which lowered body fat levels without increasing growth (since it does not raise IGF levels) or any other undesirable consequences of human growth hormone. Research on its human effectiveness is still ongoing. Research suggests that AOD-9604 has no effect on human body composition in general.
Other recent studies have demonstrated that AOD-9604 has regeneration qualities related to growth hormone in conjunction with its fat loss effects. AOD-9604 is now being tested for its use in osteoarthritis, hypercholesterolemia, and the healing of bone and cartilage.
Unlike HGH, AOD-9604 had no deleterious impact on carbohydrate metabolism, according to the results of an oral glucose tolerance test. None of the patients tested for antibody levels had any anti-AOD-9604 antibodies. AOD 9604 was not associated with any withdrawal symptoms or major side effects in any of the research investigations.
Which Advantages Does Peptide AOD 9604 Provide?
- To far, research shows that AOD-9604 Peptide has a strong fat-burning ability without causing a need to overeat.
- When administered orally, AOD-9604 Peptide stimulates fat decomposition and oxidation without activating the HGH receptor.
- AOD-9604 Peptide may help you lose weight around your middle.
- AOD-9604 Lipolysis and fat breakdown are aided by peptides. also prevents the production of fat from fat cells (the transformation of nonfat food materials into body fat)
- Processes using the peptide AOD-9604 have shown regeneration characteristics related to growth hormones.
- The blood sugar level is unaffected by the peptide.
AOD-9604 has a good safety record. AOD-9604 was tested in six double-blind, randomized, placebo-controlled studies. This drug, AOD-9604, was shown to be as safe as a placebo and had no noticeable side effects. Full-length HGH treatment’s side effects were completely avoided with AOD-9604.
Headaches, weariness, hypoglycemia, dizziness, nasopharyngitis, and cough were the most prevalent adverse effects in the trial. Hypoglycemia was also recorded. There were no unpleasant side effects. If you happen to be a researcher, you can buy AOD9604 USA for studying purposes only.